Jpmorgan Chase & CO Vericel Corp Transaction History

Jpmorgan Chase & CO

  • $1.22 Trillion
  • Q3 2024

A detailed history of Jpmorgan Chase & CO transactions in Vericel Corp stock. As of the latest transaction made, Jpmorgan Chase & CO holds 451,620 shares of VCEL stock, worth $26.6 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
451,620
Previous 479,629 5.84%
Holding current value
$26.6 Million
Previous $22 Million 13.29%
% of portfolio
0.0%
Previous 0.0%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Dec 26, 2024
SELL
$42.25 - $53.56 $1.18 Million - $1.5 Million
-28,009 Reduced 5.84%
451,620 $19.1 Million
Q3 2024

Nov 08, 2024
SELL
$42.25 - $53.56 $1.18 Million - $1.5 Million
-28,009 Reduced 5.84%
451,620 $19.1 Million
Q2 2024

Dec 26, 2024
BUY
$41.71 - $52.9 $1.17 Million - $1.48 Million
28,009 Added 6.2%
479,629 $22 Million
Q2 2024

Aug 12, 2024
SELL
$41.71 - $52.9 $1.94 Million - $2.46 Million
-46,495 Reduced 8.84%
479,629 $22 Million
Q1 2024

Dec 26, 2024
BUY
$32.52 - $52.33 $2.42 Million - $3.9 Million
74,504 Added 16.5%
526,124 $27.4 Million
Q1 2024

May 10, 2024
SELL
$32.52 - $52.33 $5.38 Million - $8.66 Million
-165,506 Reduced 23.93%
526,124 $27.4 Million
Q4 2023

Dec 26, 2024
BUY
$30.85 - $37.09 $7.4 Million - $8.9 Million
240,010 Added 53.14%
691,630 $24.6 Million
Q4 2023

Feb 12, 2024
BUY
$30.85 - $37.09 $1.88 Million - $2.26 Million
60,944 Added 9.66%
691,630 $24.6 Million
Q3 2023

Nov 14, 2023
SELL
$31.69 - $39.25 $1.65 Million - $2.04 Million
-52,000 Reduced 7.62%
630,686 $21.1 Million
Q2 2023

Aug 11, 2023
BUY
$29.0 - $38.37 $758,988 - $1 Million
26,172 Added 3.99%
682,686 $25.6 Million
Q1 2023

May 18, 2023
BUY
$23.85 - $31.34 $1.41 Million - $1.86 Million
59,279 Added 9.93%
656,514 $19.2 Million
Q1 2023

May 11, 2023
SELL
$23.85 - $31.34 $1.47 Million - $1.93 Million
-61,541 Reduced 9.34%
597,235 $17.5 Million
Q4 2022

Feb 13, 2023
SELL
$17.65 - $27.37 $168,151 - $260,753
-9,527 Reduced 1.43%
658,776 $17.4 Million
Q3 2022

Nov 14, 2022
BUY
$22.62 - $32.54 $31,238 - $44,937
1,381 Added 0.21%
668,303 $15.5 Million
Q2 2022

Aug 11, 2022
SELL
$22.88 - $39.45 $226,100 - $389,844
-9,882 Reduced 1.46%
666,922 $16.8 Million
Q1 2022

May 11, 2022
SELL
$31.69 - $43.29 $1.48 Million - $2.02 Million
-46,694 Reduced 6.45%
676,804 $25.9 Million
Q4 2021

Feb 10, 2022
SELL
$35.2 - $52.6 $1.08 Million - $1.62 Million
-30,737 Reduced 4.08%
723,498 $28.4 Million
Q3 2021

Nov 12, 2021
BUY
$46.35 - $59.75 $35 Million - $45.1 Million
754,235 New
754,235 $36.8 Million

Others Institutions Holding VCEL

# of Institutions
277
Shares Held
48.3M
Call Options Held
91.8K
Put Options Held
23.2K
View Full List

About Vericel Corp

VCEL Quotes by TradingView
  • Ticker VCEL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 47,178,000
  • Market Cap $2.78B
  • Description
  • Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...
More about VCEL
Track This Portfolio

Track Jpmorgan Chase & CO Portfolio

Follow Jpmorgan Chase & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email